Literature DB >> 15845008

Synthesis of photoactivatable acyclic analogues of the lobatamides.

Ruichao Shen1, Takao Inoue, Michael Forgac, John A Porco.   

Abstract

[structure: see text] The lobatamides and related salicylate enamide natural products are potent mammalian V-ATPase inhibitors. To probe details of binding of the lobatamides to mammalian V-ATPase, three photoactivatable analogues bearing benzophenone photoaffinity labels have been prepared. The analogues were designed on the basis of a simplified acyclic analogue 2. Late-stage installation of the enamide side chain and tandem deallylation/amidation were employed in synthetic routes to these derivatives. Simplified analogue 2 showed strong inhibition against bovine clathrin-coated vesicle V-ATPase (10 nM). Analogues 3-5 were also evaluated for inhibition of bovine V-ATPase in order to select a suitable candidate for future photoaffinity labeling studies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15845008     DOI: 10.1021/jo0477751

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  4 in total

1.  Asymmetric total synthesis and absolute stereochemistry of the neuroactive marine macrolide palmyrolide A.

Authors:  Rodolfo Tello-Aburto; Emily M Johnson; Cheyenne K Valdez; William A Maio
Journal:  Org Lett       Date:  2012-04-04       Impact factor: 6.005

2.  Generation and Reactions of ε-Carbonyl Cations via Group 13 Catalysis.

Authors:  Page M Penner; James R Green
Journal:  Molecules       Date:  2022-05-11       Impact factor: 4.927

3.  Second-Generation Synthesis of (-)-Viriditoxin.

Authors:  Charles I Grove; Jared T Shaw
Journal:  Synthesis (Stuttg)       Date:  2012       Impact factor: 3.157

4.  Binding is not enough: flexibility is needed for photocrosslinking of Lck kinase by benzophenone photoligands.

Authors:  Akira Kawamura; Sagit Hindi; Doina M Mihai; Laurence James; Olga Aminova
Journal:  Bioorg Med Chem       Date:  2008-09-03       Impact factor: 3.641

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.